Targeting Angiogenesis for Treatment of NSCLC Brain Metastases

E-ISSN： 1873-5576|12|3|289-299

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.3, 2012-03, pp. : 289-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC

By Addeo Raffaele Zappavigna Silvia Luce Amalia Facchini Sergio Caraglia Michele

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Targeting angiogenesis for the treatment of prostate cancer

By Antonarakis Emmanuel S Carducci Michael A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled

Current Molecular Pharmacology, Vol. 5, Iss. 3, 2012-11 ,pp. : 382-391

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Metastases: Treatment Options to Improve Outcomes

By Davey P.

CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. : 325-338

Adis International

Access to resources Recommend Favorite

The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases

Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-03 ,pp. : 247-259

Bentham Science Publishers

Access to resources Recommend Favorite